Salute e Benessere

Are Women on the Frontline of Antimicrobial Resistance?

National Patient Survey of Women’s Urinary Tract Infection (UTI) and Prenatal Screening reveals women suffering from UTI concerned about immediate antibiotic prescribing and Antimicrobial Resistance (AMR), especially during pregnancy.The survey was commissioned by Forte Medical, the UK based SME working to revolutionise diagnosis and treatment for Urinary Tract Infection and prenatal screening.Key survey results92% of respondents reported urine spillage onto hands, clothes, toilet...
Nasdaq GlobeNewswire
17/09/2025

Digital Health Market Is Projected to Reach US$ 1921.38 Billion By 2031 With…

The report from The Insight Partners, therefore, provides several stakeholders—including digital forensics solution providers, law enforcement & government agencies, cybersecurity firms, regulatory & standards organizations, and end-users—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. The report from The Insight Partners, therefore, provides several stakeholders—including digital forensics solution providers, law…
PR Newswire
17/09/2025

Diabetes Care Devices Market worth US$61.2 billion by 2030 with 12.3% CAGR |…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375 Browse in-depth TOC on "Diabetes Care Devices Market" 200 - Tables 60 - Figures 250 - Pages By product type,the global diabetes care devices market is divided into three main segments: blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. The blood glucose...
PR Newswire
17/09/2025

Clinical Microbiology Market worth US$7.34 billion by 2030 with 6.6% CAGR |…

Browse in-depth TOC on "Clinical Microbiology Market" Browse in-depth TOC on "Clinical Microbiology Market" 470 - Tables 53 - Figures 410 - Pages By end user,the clinical microbiology market is segmented into hospitals & diagnostic centers, contract testing laboratories, and academic & research institutes. In 2024, the diagnostic centers segment accounted for the largest market share, primarily due to the high patient volume, increasing incidence of infectious...
PR Newswire
17/09/2025

Notice of Annual General Meeting 2025

ANNOUNCEMENT NO. 293 17 September 2025Notice of Annual General Meeting Notice is hereby given of the Annual General Meeting, which will be held on Thursday 9 October 2025 at 5.30 p.m.The general meeting will be held at Nordsjællands KonferenceCenter, Gydevang 39-41, 3450 AllerødAdditional info Kim Nicolajsen, CFOTelefon (+45) 48 13 10 20About ChemoMetec A/SChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of...
Nasdaq GlobeNewswire
17/09/2025

Esaote opens new offices in Maastricht and reaffirms its presence in the…

In the Netherlands, Esaote intends to continue its growth by developing innovative solutions both in the sector of ultrasound as well as of Medical IT (in particular software solutions developed for interventional cardiologists and cardiac surgeons i.e. cardiac structural imaging, endovascular analysis, pre-operative sizing and planning). Inthe Netherlands , Esaote intends to continue itsgrowth by developing innovative solutions both in the sector of ultrasound as well as of Medical IT...
PR Newswire
17/09/2025

Advancing Cancer Research Brings New Hope for Patients Worldwide

Click here to view the custom infographic of the Oncotelic Therapeutics editorial. Clickhere to view the custom infographic of the Oncotelic Therapeutics editorial. The Pressing Demand for New Therapies Despite decades of research and billions in spending, some of the most aggressive cancers remain devastatingly lethal. Glioblastoma, the most frequently diagnosed malignant brain tumor in adults, still carries amedian survival of only about 15 months, even with surgery,...
PR Newswire
17/09/2025

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from…

SKY-0515's Phase 2/3 FALCON-HD trial in patients in Australia and New Zealand is ongoing SKY-0515's Phase 2/3 FALCON-HD trial in patients inAustraliaandNew Zealandis ongoing BOSTON , Sept. 17, 2025 /PRNewswire/ --Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today announced positive results from the first interim analysis of the Part C patient cohort in its Phase 1...
PR Newswire
17/09/2025

Insightec's Incisionless Focused Ultrasound Therapy Successfully Treats Downton…

ET is a debilitating and progressive neurological movement disorder that causes involuntary shaking, commonly of the hands and arms, but it can also affect the head, voice, and other parts of the body.3 The condition can significantly impact daily activities and quality of life, including the ability to work, with over 40% saying it impacts their ability to socialise and continue hobbies.4 ET is a debilitating and progressive neurological movement disorder that causes involuntary shaking,...
PR Newswire
17/09/2025

Amphista Therapeutics discloses first details of its SMARCA2 degrader program

Structurally-guided discovery using high-resolution cryo-EM has delivered potent, DCAF16-dependent Targeted Glues™ of SMARCA2, with exquisite selectivity over close homolog, SMARCA4.Rapid, deep and sustained degradation of SMARCA2 has been achieved, with a wide margin over SMARCA4. CNS penetrant SMARCA2 Targeted Glues™ have been identified within the program, offering the potential for differentiation to all other agents on this critical parameter. Cambridge, UK, 17 September 2025...
Nasdaq GlobeNewswire
17/09/2025

AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to…

ACUT ), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, today announced an expansion of its blood-based testing capabilities in partnership with EmeritusDX, a rapidly growing cancer diagnostics and information company. The two companies are building out their best-in-class product portfolios and respective infrastructures to meet growing clinical demand for non-invasive testing technologies.A key milestone in this expansion is the...
Nasdaq GlobeNewswire
17/09/2025

Material Testing Market worth $1,070.9 million by 2030 - Exclusive Report by…

269 - Tables49 - Figures249 - Pages 269 - Tables 49 - Figures 249 - Pages Download PDF Brochure :https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=207231755 The market for material testing is primarily driven by the growing demand for quality assurance and regulatory compliance across various industries to ensure the safety and reliability of materials. Additionally, there is a significant expansion in the demand for contracted material testing services, fueled by growth...
PR Newswire
17/09/2025

Rudholm Group Celebrates 35 Years of Global Growth Since Wollin's Visionary…

Wigan's unparalleled talent has earned him international acclaim. His works have been commissioned by Queen Elizabeth II, King Charles III, and other global icons. Each sculpture, crafted under a microscope with tools as fine as eyelashes, reflects precision, patience, and mastery, qualities that mirror the Rudholm philosophy. Wigan's unparalleled talent has earned him international acclaim. His works have been commissioned byQueen Elizabeth II,King Charles III, and other global icons...
PR Newswire
17/09/2025

China's Exporter Adapts to New Economic Realities as Canton Fair Highlights…

Moreover, Chinese technology-intensive and high-value products have won broader recognition in developed and emerging markets alike. At the 137th Canton Fair, a Rwandan buyer, facing Africa's digital shift, sealed a deal for LED/LCD displays to introduce smart solutions locally. A Pakistani buyer, noting the soaring demand for energy-saving appliances in his country, called the fair his top source for cost-effective, quality Chinese goods. These evolving demands are prompting Chinese companies…
PR Newswire
17/09/2025

Amber Implants Secures FDA 510(k) Clearance for VCFix® Spinal System: A…

One-year follow-up data from initial clinical trials of the VCFix® Spinal System, announced in June 2025, demonstrated immediate and sustained reduction in pain, improved spinal stability, and faster recovery, underscoring its potential for lasting functional benefits. Amber Implants is also working towards CE marking in the EU, aiming for broad labeling that supports both stand-alone use of VCFix®, and integration with posterior fixation systems. One-year follow-up data from initial clinical...
PR Newswire
17/09/2025

ENGWE Opens First Pop-Up Store in Germany: Accelerating European Market…

Looking ahead to 2026, ENGWE will expand its physical footprint across Germany, opening dedicated brand stores in Berlin, Munich, Frankfurt, Bochum, and Cologne, aiming to reach roughly five million riders. The company will keep showing up at Eurobike and execute a "Product + Channel + Ecosystem" strategy that pairs compelling products with accessible retail and community services to speed adoption across Europe's largest single market. Looking ahead to 2026, ENGWE will expand…
PR Newswire
17/09/2025

Implantica's RefluxStop® sparks strong excitement at the American Foregut…

As the third and final module of the PMA application nears completion, we see a massive wave of interest emerging from surgeons in the US and worldwide, also witnessed at AFS. Accordingly, Implantica has started to build the necessary infrastructure, inventory, resources, and launch teams to deliver a speedy US rollout upon the PMA approval. As the third and final module of the PMA application nears completion, we see a massive wave of interest emerging from surgeons in the US and worldwide,...
PR Newswire
17/09/2025

Press Release: EADV: Sanofi’s brivekimig achieved positive results in…

EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a studyIn phase 2a study, brivekimig led to clinically meaningful improvements in primary and key secondary endpoints in biologic-naïve patients compared to placebo at week 16Dual-target Nanobody® VHH inhibiting TNF and OX40L being explored across a range of immune-mediated diseasesReaffirms Sanofi’s commitment to addressing underlying inflammation across complex, heterogeneous chronic skin...
Nasdaq GlobeNewswire
17/09/2025

Malaysia Healthcare Week Debuts in Kuwait, Strengthening Malaysia-Kuwait Medical…

Malaysia Healthcare Week in Kuwait provides a platform to strengthen Malaysia–Kuwait bilateral healthcare collaboration while showcasing Malaysia's position as a regional healthcare leader. By highlighting Malaysia's world-class medical expertise and advanced healthcare infrastructure, the event reinforces the country's reputation for delivering exceptional patient care and supports greater collaboration in medical training and knowledge exchange. The initiative positions Malaysia as the trusted…
PR Newswire
17/09/2025

Madre Brava : 91% of European doctors and dietitians believe meat consumption…

The poll of 600 healthcare professionals in the UK, Germany, France, Spain and Italy also found a staggering 95% think health warnings should be introduced on red and processed meat, with 84% agreeing overall meat consumption is a public health concern and needs reform. The poll of 600 healthcare professionals in the UK,Germany,France,SpainandItalyalso found a staggering 95% think health warnings should be introduced on red and processed meat, with 84% agreeing overall meat...
PR Newswire
17/09/2025

EADV Congress 2025: Atopic eczema linked to significantly higher risk of…

Participants with current AE were grouped by age of AE onset – childhood, adolescence, or adulthood – and completed a detailed online questionnaire capturing sociodemographic information, self-reported suicidal ideation, severity of itch and skin pain, AE severity, and experiences of skin-related stigmatisation. Participants with current AE were grouped by age of AE onset – childhood, adolescence, or adulthood – and completed a detailed online questionnaire capturing sociodemographic...
PR Newswire
17/09/2025

KAT6 Inhibitors Market Poised for Significant Growth During the Forecast Period…

Key Takeaways from the KAT6 Inhibitors Market Report Key Takeaways from the KAT6 Inhibitors Market Report Discover which indication is expected to grab the major KAT6 inhibitors market share @KAT6 Inhibitors Market Report Key Factors Driving the KAT6 Inhibitors Market Targeting Resistance in ER+ HER2– Breast Cancer KAT6 (KAT6A and KAT6B) has emerged as a critical target in estrogen receptor-positive (ER+) HER2-negative breast cancer, particularly in patients who have...
PR Newswire
16/09/2025

Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS…

Teva will also host a conference call for analysts and investors on Monday, September 22, 2025, at 11:00 a.m. ET to discuss these data.In order to participate, please register in advancehereto obtain a local or toll-free phone number and your personal pin.To access a live webcast of the presentation, visit Teva’s Investor Relations website athttps://ir.tevapharm.com/Events-and-Presentations.An archived version of the webcast will be available within 24 hours after the end of the...
Nasdaq GlobeNewswire
16/09/2025

Digital Therapeutics Market to Surpass US$ 39.52 Billion by 2033, with a 21.6%…

Researchers from the University of Auckland highlight that for digital-native companies, commercialization and international expansion are intertwined from the start. Unlike traditional healthcare firms that expand internationally only after domestic success, digital therapeutics companies face a global market immediately, requiring them to embed global strategies early on. They must adapt to diverse regulatory and reimbursement systems, tailoring product design and business models to different…
PR Newswire
16/09/2025
Altri  Comunicati